To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Merz PharmaMerz Pharmaceuticals (Merz Pharma GmbH & Co. KGaA), a member of Merz Pharma, is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Germany, Merz is a leader in the field of Alzheimer research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology. |
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Merz_Pharma". A list of authors is available in Wikipedia. |
